SPDR S&P Pharmaceuticals ETF
XPH
XPH
71 hedge funds and large institutions have $98.4M invested in SPDR S&P Pharmaceuticals ETF in 2024 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 18 increasing their positions, 24 reducing their positions, and 8 closing their positions.
Holders
71
Holders Change
–
Holders Change %
0%
% of All Funds
1.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
18
Reduced
24
Closed
8
Calls
$834K
Puts
$1.35M
Net Calls
-$519K
Net Calls Change
+$150K
Top Buyers
| 1 |
1
BNP Paribas Financial Markets
Paris,
France
|
$6.63M |
| 2 |
2
Citigroup
New York
|
$2.22M |
| 3 |
3
Citadel Advisors
Miami,
Florida
|
$1.07M |
| 4 |
GS
4
GTS Securities
New York
|
$1.12M |
| 5 |
5
Goldman Sachs
New York
|
$2.42M |
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
76
Two Sigma Investments
New York
| – | – | -7,200 | Closed |
|
|
GLR
77
Great Lakes Retirement
Sandusky,
Ohio
| – | – | -1,438 | Closed |
|
|
NRC
78
New Republic Capital
Charlotte,
North Carolina
| – | – | -1,056 | Closed |
|
|
TFF
79
The Family Firm
Bethesda,
Maryland
| – | – | -171 | Closed |
|
|
CC
80
Cypress Capital
Franklin,
Tennessee
| – | – | -57 | Closed |
|
|
CFGS
81
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|